Bionano Genomics, Inc. BNGO
Set alert
At close
Pre-market · Nov 3, 7:47 AM ET
- YTD
- -24.18%
- 1 year
- -32.56%
- Open
- 1.17
- Prev close
- 1.15
- Mkt cap
- 16.21M
- Vol
- 89.11K
- Avg vol
- 941.89K
- EPS
- -3.02
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.14
- High
- 1.19
- Forward P/E
- -0.41
- Beta
- 2.38
- Short ratio
- 3.81
- Inst. own
- 12.81%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 7, 2024
- 50-d avg
- 0.2652
- 200-d avg
- 0.6133
- 1y target
- 1.00
5D chart
Signals (32)
| Name | Time | Ago |
|---|---|---|
| MACD: Buy Signal | Nov 2, 3:05 PM | 16 hours ago |
| MACD: Sell Signal | Nov 2, 2:40 PM | 17 hours ago |
| RSI: Oversold | Nov 2, 2:40 PM | 17 hours ago |
| MACD: Buy Signal | Nov 2, 1:30 PM | 18 hours ago |
| MACD: Sell Signal | Nov 2, 11:25 AM | 20 hours ago |
| RSI: Overbought | Nov 2, 9:30 AM | 22 hours ago |
| MACD: Buy Signal | Oct 30, 3:05 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 2:55 PM | 3 days ago |
| RSI: Oversold | Oct 30, 2:55 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 2:20 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 1:00 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 12:20 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 12:05 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 12:00 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 11:45 AM | 3 days ago |
| MACD: Buy Signal | Oct 30, 11:15 AM | 3 days ago |
| RSI: Oversold | Oct 30, 10:15 AM | 3 days ago |
| MACD: Sell Signal | Oct 30, 10:00 AM | 3 days ago |
| SMA: Bullish | Oct 29, 3:50 PM | 4 days ago |
| SMA: Bullish | Oct 29, 3:50 PM | 4 days ago |
Newest 20 of 32.
News
6 days ago globenewswire.com
Bionano to Report Third Quarter 2026 Financial Results and Host a Conference Call Webcast on November 10, 2026
SAN DIEGO, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Tuesday, November 10, 2026, at 4:30 p.m.…
1 month ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Tempest Therapeutics (NASDAQ:TPST) stock increased by 41.6% to $1.07 during Tuesday's after-market session. The company's market cap stands at $12.9 million. Jupiter Neurosciences…
1 month ago benzinga.com
Bionano Genomics Stock Surges Tuesday: What's Going On?
Bionano Genomics is surging Tuesday as investors weigh its growth strategy and favorable milestones for its genome mapping technology.
1 month ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers PDS Biotechnology (NASDAQ:PDSB) shares rose 63.7% to $0.65 during Tuesday's regular session. The market value of their outstanding shares is at $22.3 million. DataMEDS AI (NASDAQ:MEDS) shares…
-
1 month ago benzinga.com
Bionano Genomics Highlights Three New Independently Authored, Peer-Reviewed Publications Showing Clinical Utility Of OGM In High-Risk Hematologic Malignancies
Bionano Genomics, Inc. (NASDAQ:BNGO) today highlighted three new independently authored, peer-reviewed publications demonstrating the clinical utility of OGM in high-risk hematologic malignancies —…
-
1 month ago benzinga.com
Bionano Genomics Subsidiary Says MolDX Issues Proposed LCD For Genome-Wide Molecular Methodologies For Detection Of Copy Number Alterations And Structural Variants In Hematologic Neoplasms
Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (NASDAQ:BNGO) that offers CLIA-certified laboratory developed test (LDTs), today announced that MolDX, a program that…
-
2 months ago benzinga.com
Bionano Genomics Raises FY2026 Sales Guidance from $30.000M-$33.000M to $31.000M-$33.000M vs $32.137M Est
Bionano Genomics (NASDAQ:BNGO) raises FY2026 sales outlook from $30.000 million-$33.000 million to $31.000 million-$33.000 million vs $32.137 million estimate.
5 months ago benzinga.com
Transcript: Bionano Genomics Q1 2026 Earnings Conference Call
Transcript: Bionano Genomics Q1 2026 Earnings Conference Call
-
5 months ago benzinga.com
Bionano Genomics Q1 EPS $(0.76) Beats $(0.95) Estimate, Sales $6.687M Beat $6.567M Estimate
Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(0.76) per share which beat the analyst consensus estimate of $(0.95) by 20 percent. This is a 33.91 percent increase over losses of…
-
5 months ago benzinga.com
Bionano Genomics Affirms FY2026 Sales Guidance of $30.000M-$33.000M vs $32.137M Est
Bionano Genomics (NASDAQ:BNGO) affirms FY2026 sales outlook from $30.000 million-$33.000 million to $30.000 million-$33.000 million vs $32.137 million estimate.
-
5 months ago benzinga.com
Bionano Genomics Files Shelf Registration To Offer Up To $400M In Common Stock, Preferred Stock, Debt, Warrants, And Units
$400,000,000Common StockPreferred StockDebt SecuritiesWarrantsUnitsFrom time to time, we may offer and sell up to an aggregate amount of $400,000,000 of any combination of the securities described in…
-
6 months ago benzinga.com
Bionano Genomics Appoints Chairman Al Luderer Interim President, CEO, Effective Immediately
Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Al Luderer, Ph.D., chairman of Bionano's Board of Directors, has been appointed interim president and chief executive officer, effective May…
-
6 months ago benzinga.com
HC Wainwright & Co. Maintains Buy on Bionano Genomics, Lowers Price Target to $6
HC Wainwright & Co. analyst Yi Chen maintains Bionano Genomics (NASDAQ:BNGO) with a Buy and lowers the price target from $7 to $6.
7 months ago benzinga.com
Bionano Genomics Stock Soars As Efficiency Gains Meet Growth Story
Bionano Genomics stock soared on Monday as investors anticipated the company's Q4 earnings report.
-
7 months ago benzinga.com
Earnings Scheduled For March 23, 2026
Earnings Scheduled For March 23, 2026
7 months ago benzinga.com
Nasdaq Tumbles 2% Amid Rate-Hike Fears: Fear & Greed Index Remains In 'Extreme Fear' Zone
The CNN Fear & Greed Index increased due to ongoing conflicts. U.S. stocks closed lower, with Nasdaq down 2%, while energy and financial sectors gained.
7 months ago benzinga.com
United Airlines, AGI And 3 Stocks To Watch Heading Into Monday
US stock futures down, Caledonia Mining, United Airlines & Agi to report earnings, Cheetah Net & BioNano Genomics to release results.
7 months ago benzinga.com
Bionano Genomics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Bionano Genomics, Inc. (BNGO) will release Q4 earnings on March 23. Analysts expect $1.40 loss per share on $7.85M revenue. Stock closed at $1.12.
-
7 months ago benzinga.com
Bionano Announces Two-Fold Increase in OGM Studies Presented At Annual Clinical Genetics Meeting
Bionano Genomics participated in the 2026 American College of Medical Genetics and Genomics Annual Meeting (ACMG), held March 14–18 in Baltimore, Maryland. Twelve studies, representing a two-fold…
-
9 months ago benzinga.com
Bionano Genomics Publishes Study On Application Of Optical Genome Mapping To Trace Genomic Alterations Introduced By Different Gene Editing Technologies
Bionano Genomics, Inc. (Nasdaq: BNGO) announced a peer-reviewed study published in Molecular Therapy - Methods & Clinical Development, describing the application of optical genome mapping (OGM) to…
-
11 months ago benzinga.com
Bionano Laboratories Gains 47% CMS Reimbursement Increase For OGM Blood-Cancer Test Code 81195 In 2026
Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (NASDAQ:BNGO) offering CLIA-certified laboratory developed tests (LDTs) based on optical genome mapping (OGM), announced…
11 months ago benzinga.com
Baidu To Rally More Than 69%? Here Are 10 Top Analyst Forecasts For Monday
Baidu To Rally More Than 69%? Here Are 10 Top Analyst Forecasts For Monday
-
11 months ago benzinga.com
HC Wainwright & Co. Maintains Buy on Bionano Genomics, Lowers Price Target to $7
HC Wainwright & Co. analyst Yi Chen maintains Bionano Genomics (NASDAQ:BNGO) with a Buy and lowers the price target from $11 to $7.
-
11 months ago benzinga.com
Bionano Genomics Affirms FY2025 Sales Guidance of $26.000M-$30.000M vs $28.136M Est
Bionano Genomics (NASDAQ:BNGO) affirms FY2025 sales outlook from $26.000 million-$30.000 million to $26.000 million-$30.000 million vs $28.136 million estimate.
-
11 months ago benzinga.com
Bionano Genomics Q3 EPS $(1.59) Beats $(1.91) Estimate, Sales $7.367M Beat $6.871M Estimate
Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(1.59) per share which beat the analyst consensus estimate of $(1.91) by 16.75 percent. This is a 94.86 percent increase over losses of…
-
11 months ago benzinga.com
Bionano Genomics Q3 Sales $7.367M Beat $6.871M Estimate
Bionano Genomics (NASDAQ:BNGO) reported quarterly sales of $7.367 million which beat the analyst consensus estimate of $6.871 million by 7.22 percent. This is a 21.31 percent increase over sales of…
-
11 months ago benzinga.com
Earnings Scheduled For November 13, 2025
Earnings Scheduled For November 13, 2025
-
12 months ago benzinga.com
Bionano Genomics Publishes Study Demonstrating That Optical Genome Mapping Can Overcome Key Limitations Of Targeted RNA-Sequencing Panels In Detecting Therapeutically Relevant Gene Rearrangements In Acute Leukemia
Bionano Genomics, Inc. (NASDAQ:BNGO) today announced the publication of a study in Cancers from The University of Texas MD Anderson Cancer Center showing how optical genome mapping (OGM) can address…
-
1 year ago benzinga.com
Bionano Genomics Highlighted Expanding Role Of Optical Genome Mapping In Genetic Disease Research At ASHG Conference
Bionano Genomics, Inc. (NASDAQ:BNGO) participated in The American Society of Human Genetics (ASHG) conference from October 14–18, 2025 in Boston. The event highlighted the potential for an expanding…
1 year ago benzinga.com
Crude Oil Rises Over 2%; Bionano Genomics Shares Plunge
Crude Oil Rises Over 2%; Bionano Genomics Shares Plunge
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
1 year ago benzinga.com
Why BioNano Genomics (BNGO) Stock Is Getting Hammered Tuesday
BioNano Genomics shares are trading sharply lower in Tuesday's session. The company announced the pricing of a $10 million public offering.
1 year ago benzinga.com
Dow Falls Over 100 Points; US Retail Sales Top Estimates
Dow Falls Over 100 Points; US Retail Sales Top Estimates
-
1 year ago benzinga.com
Bionano Genomics Prices $10M Public Offering Of 5M Shares And Series Warrants At A Combined Price Of $2.00; Could Potentially Earn $20M From Warrant Exercises
Bionano Genomics, Inc. (NASDAQ:BNGO) ("Bionano" or the "Company") today announced the pricing of a public offering of an aggregate of 5,000,000 shares of the Company's common stock (or common stock…
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's Intraday Session
-
1 year ago benzinga.com
Bionano Genomics Selected For Sole Source Contract By NIH For Optical Genome Mapping Reagents And Instruments; No Contract Value Disclosed
https://sam.gov/opp/7a19a6e8954c4de1a128b841e2018400/view DescriptionThis is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be…
-
1 year ago benzinga.com
HC Wainwright & Co. Maintains Buy on Bionano Genomics, Raises Price Target to $11
HC Wainwright & Co. analyst Yi Chen maintains Bionano Genomics (NASDAQ:BNGO) with a Buy and raises the price target from $10 to $11.
-
1 year ago benzinga.com
Bionano Genomics Q2 EPS $(1.99) Beats $(2.42) Estimate, Sales $6.733M Miss $6.832M Estimate
Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(1.99) per share which beat the analyst consensus estimate of $(2.42) by 17.6 percent. This is a 86.18 percent increase over losses of…
-
1 year ago benzinga.com
Bionano Genomics Affirms FY2025 Sales Guidance of $26.000M-$30.000M vs $29.363M Est
Bionano Genomics (NASDAQ:BNGO) affirms FY2025 sales outlook from $26.000 million-$30.000 million to $26.000 million-$30.000 million vs $29.363 million estimate.
-
1 year ago benzinga.com
Bionano Genomics Sees Q3 Sales $6.700M-$7.200M vs $7.661M Est
Bionano Genomics (NASDAQ:BNGO) sees Q3 sales of $6.700 million-$7.200 million vs $7.661 million analyst estimate.
-
1 year ago benzinga.com
Earnings Scheduled For August 14, 2025
Earnings Scheduled For August 14, 2025
-
1 year ago benzinga.com
A Preview Of Bionano Genomics's Earnings
A Preview Of Bionano Genomics's Earnings
-
1 year ago benzinga.com
Bionano Genomics Announces Peer-Reviewed Study Showing That Optical Genome Mapping Can Effectively Detect Oncogenic Structural Variants In Infant And Toddler T-cell Acute Lymphoblastic Leukemia
Bionano Genomics, Inc. (NASDAQ:BNGO) today announced a peer-reviewed publication from a team led by Manon Delafoy from the Institut Necker Enfants Malades (INEM) and colleagues from multiple French…
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
-
1 year ago benzinga.com
Earnings Scheduled For November 13, 2024
Earnings Scheduled For November 13, 2024
-
2 years ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session